Literature DB >> 6603519

Studies of the kallikrein-kinin system in patients with sickle cell anemia.

R L Miller, P S Verma, R G Adams.   

Abstract

Eight patients with sickle cell anemia (SS hemoglobin) were found to have decreased plasma levels of prekallikrein compared to normal control subjects or patients with other types of anemia. The prekallikrein levels in the patients with sickle cell anemia were found to decrease further during a sickle cell crisis. These results suggest that components of the kallikrein-kinin system are profoundly affected in patients with sickle cell anemia, and during crises may play a role in the clinical presentation of patients.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6603519      PMCID： PMC2561580     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


  11 in total

1.  Interaction of leukocytes and endotoxin with the plasmin and kinin systems.

Authors:  R L Miller; M E Webster; K L Melmon
Journal:  Eur J Pharmacol       Date:  1975-08       Impact factor: 4.432

2.  Activation of surface-bound Hageman factor: pre-eminent role of high molecular weight kininogen and evidence for a new factor.

Authors:  M E Webster; J A Guimaraes; A P Kaplan; R W Colman; J V Pierce
Journal:  Adv Exp Med Biol       Date:  1976       Impact factor: 2.622

Review 3.  Role of coagulation system in pathophysiology of sickle cell disease.

Authors:  F R Rickles; D S O'Leary
Journal:  Arch Intern Med       Date:  1974-04

4.  Serum protein profile in sickle cell disease.

Authors:  U P Isichei
Journal:  J Clin Pathol       Date:  1979-02       Impact factor: 3.411

5.  Kallikrein-bradykinin system in chronic alcoholic liver disease.

Authors:  P Wong; R W Colman; R C Talamo; B M Babior
Journal:  Ann Intern Med       Date:  1972-08       Impact factor: 25.391

6.  A radioimmunoassay for bradykinin in plasma and synovial fluid.

Authors:  R C Talamo; E Haber; K F Austen
Journal:  J Lab Clin Med       Date:  1969-11

7.  The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states.

Authors:  R W Colman; J W Mason; S Sherry
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

8.  Hemostatic alterations accompanying sickle cell pain crises.

Authors:  N Alkjaersig; A Fletcher; H Joist; H Chaplin
Journal:  J Lab Clin Med       Date:  1976-09

9.  Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease.

Authors:  H Saito; M C Poon; W Vicic; G H Goldsmith; J E Menitove
Journal:  J Lab Clin Med       Date:  1978-07

10.  The liver in sickle cell disease. A clinicopathologic study of 70 patients.

Authors:  T W Bauer; G W Moore; G M Hutchins
Journal:  Am J Med       Date:  1980-12       Impact factor: 4.965
View more
  7 in total

1.  Red blood cells and thrombin generation in sickle cell disease.

Authors:  Matthew F Whelihan; Ming Y Lim; Nigel S Key
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

Review 2.  Sickle cell disease: an inherited thrombophilia.

Authors:  Ted Wun; Ann Brunson
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 3.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

Review 4.  How I diagnose and treat venous thromboembolism in sickle cell disease.

Authors:  Arun S Shet; Ted Wun
Journal:  Blood       Date:  2018-05-15       Impact factor: 22.113

Review 5.  Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.

Authors:  Denis Noubouossie; Nigel S Key; Kenneth I Ataga
Journal:  Blood Rev       Date:  2015-12-24       Impact factor: 8.250

Review 6.  Linking Labile Heme with Thrombosis.

Authors:  Marie-Thérèse Hopp; Diana Imhof
Journal:  J Clin Med       Date:  2021-01-22       Impact factor: 4.241

7.  Inhibition of plasma kallikrein by a highly specific active site blocking antibody.

Authors:  Jon A Kenniston; Ryan R Faucette; Diana Martik; Stephen R Comeau; Allison P Lindberg; Kris J Kopacz; Gregory P Conley; Jie Chen; Malini Viswanathan; Niksa Kastrapeli; Janja Cosic; Shauna Mason; Mike DiLeo; Jan Abendroth; Petr Kuzmic; Robert C Ladner; Thomas E Edwards; Christopher TenHoor; Burt A Adelman; Andrew E Nixon; Daniel J Sexton
Journal:  J Biol Chem       Date:  2014-06-26       Impact factor: 5.157
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.